Analyst Ratings for Nektar Therapeutics (NKTR)
NKTR Rating Summary
NKTR Price Target Summary
- Highest: $151.00 (BTIG)
- Lowest: $102.00 (Citi)
- Average: $125.57
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$125.57 (+77.6%)
* Over Last 12-Mos
Rating Score: 6.5 / 10
Percentile Rank: 69%
Avg. $ Target:
$125.57 (+77.6%)
* Over Last 12-Mos
Rating Score: 6.5 / 10
Percentile Rank: 69%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/10/2026 | William Blair | Andy Hsieh | Upgrade | Outperform (Market Perform) |
N/A (N/A) |
37.07 (70.70) |
90.72% | Details |
| 11/26/2025 | Citi | Samantha Semenkow | New Coverage | Buy (N/A) |
102.00 (N/A) |
60.35 (70.70) |
17.15% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
